FHA
BOLD

Flagship Harbor Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Flagship Harbor Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50
Closed -$3K – 2044
2019
Q4 		$3K Hold
50
– – ﹤0.01% 1683
2019
Q3 		$1K Hold
50
– – ﹤0.01% 1818
2019
Q2 		$1K Hold
50
– – ﹤0.01% 1837
2019
Q1 		$1K Hold
50
– – ﹤0.01% 1815
2018
Q4 		$1K Hold
50
– – ﹤0.01% 1806
2018
Q3 		$2K Hold
50
– – ﹤0.01% 1948
2018
Q2 		$1K Buy
+50
New +$1.85K ﹤0.01% 1994

Flagship Harbor Advisors's BOLD Position: Q1 2020 in Review

Flagship Harbor Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 50 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in BOLD in Q2 2018 and held it in 7 quarters. The position peaked at $3K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Flagship Harbor Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 50 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 7 quarters.
  • Flagship Harbor Advisors's Audentes Therapeutics, Inc position peaked at $3K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Flagship Harbor Advisors's 13F filing for Q1 2020, filed 12 May 2020.